These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27203797)

  • 1. A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models.
    van Amerongen G; de Boer MW; Groeneveld GJ; Hay JL
    Br J Clin Pharmacol; 2016 Oct; 82(4):903-22. PubMed ID: 27203797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
    Jørum E; Warncke T; Stubhaug A
    Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
    Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
    Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
    Mathiesen O; Imbimbo BP; Hilsted KL; Fabbri L; Dahl JB
    J Pain; 2006 Aug; 7(8):565-74. PubMed ID: 16885013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
    Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
    Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man.
    Bickel A; Dorfs S; Schmelz M; Forster C; Uhl W; Handwerker OH
    Pain; 1998 Jun; 76(3):317-325. PubMed ID: 9718250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynurenine in healthy volunteers.
    Wallace M; White A; Grako KA; Lane R; Cato AJ; Snodgrass HR
    Scand J Pain; 2017 Oct; 17():243-251. PubMed ID: 29229209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine.
    Koppert W; Dern SK; Sittl R; Albrecht S; Schüttler J; Schmelz M
    Anesthesiology; 2001 Aug; 95(2):395-402. PubMed ID: 11506112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia.
    Gottrup H; Juhl G; Kristensen AD; Lai R; Chizh BA; Brown J; Bach FW; Jensen TS
    Anesthesiology; 2004 Dec; 101(6):1400-8. PubMed ID: 15564948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs attenuate agonist-evoked activation of transient receptor potential channels.
    Tsagareli MG; Nozadze I; Tsiklauri N; Gurtskaia G
    Biomed Pharmacother; 2018 Jan; 97():745-751. PubMed ID: 29102918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
    Warncke T; Stubhaug A; Jørum E
    Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.
    Pöyhiä R; Vainio A
    Clin J Pain; 2006 Jan; 22(1):32-6. PubMed ID: 16340591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
    Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization.
    Petersen KL; Maloney A; Hoke F; Dahl JB; Rowbotham MC
    J Pain; 2003 Sep; 4(7):400-6. PubMed ID: 14622682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of spinal glutamatergic receptors in post-thermal injury-evoked tactile allodynia and thermal hyperalgesia.
    Nozaki-Taguchi N; Yaksh TL
    Anesthesiology; 2002 Mar; 96(3):617-26. PubMed ID: 11873037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats.
    Malan TP; Ossipov MH; Gardell LR; Ibrahim M; Bian D; Lai J; Porreca F
    Pain; 2000 May; 86(1-2):185-94. PubMed ID: 10779675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
    Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
    J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist.
    Courteix C; Privat AM; Pélissier T; Hernandez A; Eschalier A; Fialip J
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1237-45. PubMed ID: 17551093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.
    Lomas LM; Barrett AC; Terner JM; Lysle DT; Picker MJ
    Psychopharmacology (Berl); 2007 Apr; 191(2):273-85. PubMed ID: 17225166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.